VBI Vaccines Correlations
VBIVQ Stock | 0.0005 0.0001 16.67% |
The current 90-days correlation between VBI Vaccines and Kura Sushi USA is -0.24 (i.e., Very good diversification). The correlation of VBI Vaccines is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
VBI Vaccines Correlation With Market
Significant diversification
The correlation between VBI Vaccines and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding VBI Vaccines and DJI in the same portfolio, assuming nothing else is changed.
VBI |
Moving together with VBI Stock
0.8 | FNCH | Finch Therapeutics | PairCorr |
0.61 | HURA | TuHURA Biosciences Symbol Change | PairCorr |
0.73 | NAVB | Navidea Biopharmaceutica | PairCorr |
0.7 | NWBO | Northwest Biotherapeutics | PairCorr |
Moving against VBI Stock
0.54 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
0.44 | FRTX | Fresh Tracks Therapeutics | PairCorr |
0.4 | FBIOP | Fortress Biotech Pref | PairCorr |
0.33 | UPB | Upstream Bio, | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between VBI Stock performing well and VBI Vaccines Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze VBI Vaccines' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
KRUS | 2.65 | 0.09 | 0.04 | 0.07 | 3.34 | 6.67 | 15.74 | |||
AWLCF | 0.08 | (0.05) | 0.00 | (0.87) | 0.00 | 0.00 | 2.54 | |||
RIG | 2.32 | (0.38) | 0.00 | (0.47) | 0.00 | 4.94 | 14.43 | |||
WEST | 2.80 | (0.12) | 0.00 | (0.02) | 0.00 | 6.50 | 18.80 | |||
PTEN | 2.17 | (0.17) | 0.00 | (0.07) | 0.00 | 3.86 | 18.37 | |||
CNNE | 1.14 | 0.05 | 0.04 | 0.08 | 1.25 | 2.76 | 6.89 | |||
DPZ | 1.18 | 0.01 | 0.01 | 0.04 | 1.34 | 3.26 | 8.71 |
VBI Vaccines Corporate Management
FRCPC MD | Chief Officer | Profile | |
Avi Mazaltov | Global SciVac | Profile | |
Misha Nossov | Senior Europe | Profile | |
David Anderson | Chief Officer | Profile |